rituximab,polatuzumab vedotin
roche
['nhl', 'fomo', 'lymsm', 'polarix', ' ipi ']
herra #ash22 #lymsm
avenio ctdna @ bl &amp; c2d1 of polarix
n=621
ctdna change similar btw arms (sim to crr)
cleared ctdna @ c2d1 a/w v good prog - 2ypfs 90% 2.5x log fold drop @ c2d1 prognostic, but dif prob not big enough to guide rx imo 
Doc from Melbourne, Australia. Treats patients with blood cancers and researches new therapies. Loves family, immersive theatre and running.